EVERLIGHT CHEMICAL INDUSTRIAL CORP

Overview

EVERLIGHT CHEMICAL INDUSTRIAL CORP is an active pharmaceutical ingredient (API) supplier with 11 active FDA Type II Drug Master Files, covering ALPROSTADIL; BIMATOPROST; FELODIPINE; LATANOPROST; LATANOPROSTENE BUNOD; LUBIPROSTONE.

API / Drug Master Files

EVERLIGHT CHEMICAL INDUSTRIAL CORP holds 11 active (15 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• LATANOPROSTENE BUNODActive2023-12-27
• TREPROSTINIL DIOLAMINEActive2016-04-28
• TAFLUPROSTActive2015-07-15
• RASAGILINE MESYLATEActive2011-12-27
• LUBIPROSTONEActive2009-12-17
• BIMATOPROSTActive2008-10-14
• LATANOPROSTActive2008-04-04
• ALPROSTADILActive2008-01-15
• FELODIPINEActive2003-12-10
• MISOPROSTOL - HPMC 1% DISPERSIONActive2003-11-25
• MISOPROSTOLActive2000-08-17
• TRAVOPROSTInactive2011-09-02
• EPOPROSTENOL SODIUMInactive2008-02-05
• MISOPROSTOLInactive1999-10-21
• G SITE FACILITIES OPERATING PROCEDURES AND PERSONEL FOR FACTORY LOCATED IN TAOYUAN HSIEN TAIWANInactive1999-10-21

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to EVERLIGHT CHEMICAL INDUSTRIAL CORP in our records. PharmaTek screens the full directory against live FDA enforcement data.